P63 induced expression of many p53-target genes that were involved in cell-cycle arrest and apoptosis, so p63 is useful in distinguishing non-small cell lung carcinoma patients with or without EGFR/KRAS mutation [42]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.